Mutations in NRAS and BRAF genes, seen in a significant proportion of melanoma cases, lead to dysregulated signaling and persistent ERK activation, promoting cancer cell growth, melanoma development, and immune evasion [45]. The gene discussed is BRAF; the disease is melanoma.